Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

And those are AD, asthma, COPD, as you can see from the slide ... As seen in the pathway image on the right, IRF5 is a central node activated downstream of pattern recognition receptors that ...

From teenagers to elderly citizens, public smoking is ambiguous while the distinct smell of tobacco follows pedestrians past ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

High levels of perceived stress are associated with a quadrupled risk of moderate or severe COPD flare-ups (excerbations), ...

Summer brings unique challenges for patients with COPD. Learn how rising temperatures and humidity affect symptoms and what ...

Respiratory syncytial virus often mimics a common cold, but in older adults, this contagious virus can quickly lead to severe ...

treatment with mepolizumab resulted in a lower annualized rate of moderate or severe exacerbations when added to background triple inhaled therapy in a broad population of patients with COPD and ...

as well as how to choose a virtual background image that suits your needs. Blurring your Zoom background hides your personal space, ensuring you’re equipped for a video meeting. (Image source ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD ... into the study were receiving background therapy, mainly with either long ...

After the task was completed, participants were tested for their memory of the background distractor, even though they were told to ignore these distractors. They found the upsetting distractors ...